• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Estimating the effects of time-varying exposures in observational studies using Cox models with stabilized weights adjustment.使用具有稳定权重调整的Cox模型在观察性研究中估计随时间变化的暴露因素的影响。
Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):812-8. doi: 10.1002/pds.3601. Epub 2014 Mar 4.
2
Extension of Kaplan-Meier methods in observational studies with time-varying treatment.在具有时变治疗的观察性研究中扩展 Kaplan-Meier 方法。
Value Health. 2012 Jan;15(1):167-74. doi: 10.1016/j.jval.2011.07.010. Epub 2011 Oct 1.
3
Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.氯吡格雷在裸金属支架和药物洗脱支架置入后的长期应用:退伍军人事务部药物洗脱支架研究。
Circ Cardiovasc Interv. 2012 Jun;5(3):372-80. doi: 10.1161/CIRCINTERVENTIONS.111.967257. Epub 2012 Jun 5.
4
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).支架置入术后联合西洛他唑与氯吡格雷双倍剂量治疗:HOST-ASSURE 随机试验(优化药物洗脱支架治疗策略以确保安全性和有效性及抗血小板方案的冠状动脉狭窄的协调性研究)。
JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.
5
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.经药物洗脱支架治疗的患者阿司匹林和氯吡格雷低反应性的影响:一项前瞻性、多中心注册研究的 2 年结果。
JACC Cardiovasc Interv. 2017 Aug 28;10(16):1607-1617. doi: 10.1016/j.jcin.2017.05.059. Epub 2017 Aug 2.
6
6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).抗阿司匹林药物洗脱支架植入术后 6 个月与 24 个月双联抗血小板治疗:ITALIC 试验(停用氯吡格雷后 DES 是否仍有生命力)的最终结果。
JACC Cardiovasc Interv. 2017 Jun 26;10(12):1202-1210. doi: 10.1016/j.jcin.2017.03.049.
7
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.常规评估氯吡格雷抵抗血小板活性和基因多态性在预测药物洗脱支架植入术后稳定型冠状动脉疾病患者的临床结局。
JACC Cardiovasc Interv. 2013 Nov;6(11):1166-75. doi: 10.1016/j.jcin.2013.06.010.
8
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).药物洗脱支架经皮冠状动脉介入治疗后高血小板反应性临床影响的性别差异:ADAPT-DES研究(药物洗脱支架双重抗血小板治疗评估)结果
Circ Cardiovasc Interv. 2017 Feb;10(2). doi: 10.1161/CIRCINTERVENTIONS.116.003577.
9
Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.急性冠状动脉综合征患者药物洗脱支架置入术后,氯吡格雷与阿司匹林联合应用30个月与12个月双联抗血小板治疗的成本效益分析。
Clin Cardiol. 2017 Oct;40(10):789-796. doi: 10.1002/clc.22756. Epub 2017 Jul 6.
10
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.慢性肾脏病与经皮冠状动脉介入治疗的急性冠状动脉综合征患者使用普拉格雷与氯吡格雷治疗结局的相关性:来自 PROMETHEUS 研究的报告。
JACC Cardiovasc Interv. 2017 Oct 23;10(20):2017-2025. doi: 10.1016/j.jcin.2017.02.047. Epub 2017 Aug 2.

引用本文的文献

1
Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor-Associated Reduction in Heart Failure Hospitalizations.平等治疗,结果却不平等?揭穿肾素血管紧张素醛固酮系统抑制剂相关的心力衰竭住院率降低中的种族差异
J Card Fail. 2025 May;31(5):800-809. doi: 10.1016/j.cardfail.2024.09.012. Epub 2024 Oct 22.
2
A propensity score approach and a partitioned approach for the self-controlled case series design to evaluate safety of a 2-dose vaccine series: application to myocarditis/pericarditis following mRNA COVID-19 vaccination.一种倾向评分方法和一种用于自我对照病例系列设计以评估两剂疫苗系列安全性的分区方法:应用于mRNA新冠疫苗接种后的心肌炎/心包炎
Am J Epidemiol. 2025 Jan 8;194(1):254-266. doi: 10.1093/aje/kwae141.
3
Antipsychotic Medication and Risk of Metabolic Disorders in People With Schizophrenia: A Longitudinal Study Using the UK Clinical Practice Research Datalink.抗精神病药物与精神分裂症患者代谢紊乱风险:一项使用英国临床实践研究数据库的纵向研究。
Schizophr Bull. 2024 Mar 7;50(2):447-459. doi: 10.1093/schbul/sbad126.
4
The effects of long-term exposure to air pollution on incident mental disorders among patients with prediabetes and diabetes: Findings from a large prospective cohort.长期暴露于空气污染对糖尿病前期和糖尿病患者新发精神障碍的影响:一项大型前瞻性队列研究的结果。
Sci Total Environ. 2023 Nov 1;897:165235. doi: 10.1016/j.scitotenv.2023.165235. Epub 2023 Jul 5.
5
QTc-interval prolongation and increased risk of sudden cardiac death associated with hydroxychloroquine.羟氯喹可延长 QT 间期并增加心源性猝死风险。
Eur J Prev Cardiol. 2022 Feb 3;28(17):1875-1882. doi: 10.1093/eurjpc/zwaa118.
6
Cumulative Resting Heart Rate Exposure and Risk of All-Cause Mortality: Results from the Kailuan Cohort Study.静息心率累积暴露与全因死亡率的关系:来自开滦队列研究的结果。
Sci Rep. 2017 Jan 9;7:40212. doi: 10.1038/srep40212.

本文引用的文献

1
Extension of Kaplan-Meier methods in observational studies with time-varying treatment.在具有时变治疗的观察性研究中扩展 Kaplan-Meier 方法。
Value Health. 2012 Jan;15(1):167-74. doi: 10.1016/j.jval.2011.07.010. Epub 2011 Oct 1.
2
Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent).药物洗脱支架置入后氯吡格雷治疗患者出血风险增加:来自 HMO 研究网络-支架登记处(HMORN-stent)的见解。
Circ Cardiovasc Interv. 2010 Jun 1;3(3):230-5. doi: 10.1161/CIRCINTERVENTIONS.109.919001. Epub 2010 May 4.
3
Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals.使用稳定化反倾向得分作为权重直接估计相对风险及其置信区间。
Value Health. 2010 Mar-Apr;13(2):273-7. doi: 10.1111/j.1524-4733.2009.00671.x. Epub 2009 Nov 12.
4
Relation between three classes of structural models for the effect of a time-varying exposure on survival.时变暴露对生存影响的三类结构模型之间的关系。
Lifetime Data Anal. 2010 Jan;16(1):71-84. doi: 10.1007/s10985-009-9135-3. Epub 2009 Nov 6.
5
Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.糖尿病合并初发冠状动脉病变患者中氯吡格雷用药时长和支架类型的长期预后
J Am Coll Cardiol. 2008 Jun 10;51(23):2220-7. doi: 10.1016/j.jacc.2008.01.063.
6
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.药物洗脱支架植入术后氯吡格雷的使用与长期临床结局
JAMA. 2007 Jan 10;297(2):159-68. doi: 10.1001/jama.297.2.joc60179. Epub 2006 Dec 5.
7
On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]).
Am J Cardiol. 2006 May 15;97(10):1478-81. doi: 10.1016/j.amjcard.2005.11.081. Epub 2006 Mar 29.
8
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.强效抗逆转录病毒疗法预防艾滋病和死亡的长期有效性:一项前瞻性队列研究。
Lancet. 2005;366(9483):378-84. doi: 10.1016/S0140-6736(05)67022-5.
9
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.氯吡格雷与阿司匹林联合应用于非ST段抬高型急性冠状动脉综合征患者外科血运重建的获益与风险:氯吡格雷用于不稳定型心绞痛预防再发缺血事件(CURE)试验
Circulation. 2004 Sep 7;110(10):1202-8. doi: 10.1161/01.CIR.0000140675.85342.1B. Epub 2004 Aug 16.
10
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.氯吡格雷与阿司匹林预处理后长期治疗对接受经皮冠状动脉介入治疗患者的影响:PCI-CURE研究
Lancet. 2001 Aug 18;358(9281):527-33. doi: 10.1016/s0140-6736(01)05701-4.

使用具有稳定权重调整的Cox模型在观察性研究中估计随时间变化的暴露因素的影响。

Estimating the effects of time-varying exposures in observational studies using Cox models with stabilized weights adjustment.

作者信息

Xu Stanley, Shetterly Susan, Raebel Marsha A, Ho P Michael, Tsai Thomas T, Magid David

机构信息

Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA; University of Colorado, Denver, CO, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):812-8. doi: 10.1002/pds.3601. Epub 2014 Mar 4.

DOI:10.1002/pds.3601
PMID:24596337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4351798/
Abstract

PURPOSE

Assessing the safety and effectiveness of medical products with observational electronic medical record data is challenging when the treatment is time-varying. The objective of this paper is to develop a Cox model stratified by event times with stabilized weights (SWs) adjustment to examine the effect of time-varying treatment in observational studies.

METHODS

Time-varying SWs are calculated at unique event times and are used in a Cox model stratified by event times to estimate the effect of time-varying treatment. We applied this method in examining the effect of an antiplatelet agent, clopidogrel, on events, including bleeding, myocardial infarction, and death after a drug-eluting stent was implanted in coronary artery. Clopidogrel use may change over time on the basis of patients' behavior (e.g., non-adherence) and physicians' recommendations (e.g., end of duration of therapy). We also compared the results with those from a Cox model for counting processes adjusting for all covariates used in creating SWs.

RESULTS

We demonstrate that the (i) results from the stratified Cox model without SWs adjustment and the Cox model for counting processes without covariate adjustment are identical in analyzing the clopidogrel data; and (ii) the effects of clopidogrel on bleeding, myocardial infarction, and death are larger in the stratified Cox model with SWs adjustment compared with those from the Cox model for counting processes with covariate adjustment.

CONCLUSIONS

The Cox model stratified by event times with time-varying SWs adjustment is useful in estimating the effect of time-varying treatments in observational studies while balancing for known confounders.

摘要

目的

当治疗是随时间变化时,利用观察性电子病历数据评估医疗产品的安全性和有效性具有挑战性。本文的目的是开发一种通过事件时间分层并进行稳定权重(SWs)调整的Cox模型,以检验观察性研究中随时间变化的治疗效果。

方法

在唯一的事件时间计算随时间变化的SWs,并将其用于按事件时间分层的Cox模型中,以估计随时间变化的治疗效果。我们将此方法应用于检验抗血小板药物氯吡格雷对冠状动脉植入药物洗脱支架后的出血、心肌梗死和死亡等事件的影响。氯吡格雷的使用可能会根据患者的行为(如不依从)和医生的建议(如治疗疗程结束)随时间而变化。我们还将结果与用于计数过程的Cox模型的结果进行了比较,该模型对创建SWs时使用的所有协变量进行了调整。

结果

我们证明(i)在分析氯吡格雷数据时,未进行SWs调整的分层Cox模型和未进行协变量调整的计数过程Cox模型的结果相同;(ii)与进行协变量调整的计数过程Cox模型相比,进行SWs调整的分层Cox模型中氯吡格雷对出血、心肌梗死和死亡的影响更大。

结论

通过事件时间分层并进行随时间变化的SWs调整的Cox模型,在平衡已知混杂因素的同时,有助于估计观察性研究中随时间变化的治疗效果。